Concepts (134)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Electronic Nicotine Delivery Systems | 7 | 2025 | 58 | 2.450 |
Why?
|
| Diet, High-Fat | 3 | 2025 | 59 | 1.490 |
Why?
|
| Nicotine | 7 | 2025 | 144 | 1.230 |
Why?
|
| RNA-Binding Proteins | 3 | 2023 | 11 | 1.180 |
Why?
|
| Apoptosis Regulatory Proteins | 3 | 2023 | 17 | 1.170 |
Why?
|
| Apoptosis | 3 | 2020 | 179 | 0.880 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 2 | 2024 | 35 | 0.810 |
Why?
|
| Cotinine | 3 | 2020 | 21 | 0.790 |
Why?
|
| Endoribonucleases | 1 | 2023 | 4 | 0.790 |
Why?
|
| Mice | 8 | 2025 | 746 | 0.740 |
Why?
|
| Animals | 14 | 2025 | 1875 | 0.730 |
Why?
|
| Myocytes, Cardiac | 2 | 2020 | 23 | 0.700 |
Why?
|
| Mice, Obese | 1 | 2020 | 16 | 0.660 |
Why?
|
| Mice, Inbred C57BL | 7 | 2025 | 258 | 0.660 |
Why?
|
| Myocardium | 1 | 2020 | 25 | 0.650 |
Why?
|
| Heart | 1 | 2020 | 25 | 0.650 |
Why?
|
| Smoking | 1 | 2020 | 86 | 0.630 |
Why?
|
| Fatty Liver | 2 | 2024 | 59 | 0.610 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2020 | 93 | 0.600 |
Why?
|
| Diet, Western | 1 | 2019 | 8 | 0.590 |
Why?
|
| Liver Cirrhosis | 1 | 2019 | 58 | 0.560 |
Why?
|
| Oxidative Stress | 5 | 2024 | 102 | 0.540 |
Why?
|
| Male | 8 | 2025 | 3671 | 0.390 |
Why?
|
| Fibroblasts | 2 | 2014 | 53 | 0.380 |
Why?
|
| Cellular Senescence | 2 | 2014 | 8 | 0.320 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2020 | 13 | 0.310 |
Why?
|
| Vaping | 2 | 2019 | 26 | 0.290 |
Why?
|
| Nicotinic Agonists | 2 | 2019 | 38 | 0.290 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2008 | 29 | 0.290 |
Why?
|
| AMP-Activated Protein Kinases | 2 | 2025 | 28 | 0.230 |
Why?
|
| Muscle, Skeletal | 1 | 2025 | 75 | 0.220 |
Why?
|
| Humans | 6 | 2023 | 6794 | 0.220 |
Why?
|
| Niacinamide | 1 | 2024 | 5 | 0.210 |
Why?
|
| Pyridinium Compounds | 1 | 2024 | 6 | 0.210 |
Why?
|
| Disease Models, Animal | 3 | 2019 | 231 | 0.210 |
Why?
|
| Primate Diseases | 2 | 2013 | 2 | 0.200 |
Why?
|
| Hep G2 Cells | 1 | 2023 | 7 | 0.200 |
Why?
|
| Palmitates | 1 | 2023 | 5 | 0.200 |
Why?
|
| Obesity | 1 | 2025 | 226 | 0.200 |
Why?
|
| Fatty Acids | 1 | 2023 | 25 | 0.200 |
Why?
|
| Picornaviridae | 2 | 2012 | 2 | 0.190 |
Why?
|
| Picornaviridae Infections | 2 | 2012 | 2 | 0.190 |
Why?
|
| Mice, Knockout | 2 | 2019 | 150 | 0.180 |
Why?
|
| DNA Damage | 2 | 2014 | 20 | 0.180 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2019 | 14 | 0.180 |
Why?
|
| Blotting, Western | 2 | 2019 | 110 | 0.170 |
Why?
|
| Macaca mulatta | 2 | 2013 | 8 | 0.170 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2020 | 10 | 0.170 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2020 | 19 | 0.170 |
Why?
|
| Echocardiography | 1 | 2020 | 15 | 0.170 |
Why?
|
| Heart Ventricles | 1 | 2020 | 15 | 0.170 |
Why?
|
| Animals, Newborn | 1 | 2020 | 112 | 0.160 |
Why?
|
| Aerosols | 1 | 2019 | 15 | 0.150 |
Why?
|
| Behavior, Animal | 1 | 2019 | 30 | 0.150 |
Why?
|
| Biopsy, Needle | 1 | 2019 | 12 | 0.150 |
Why?
|
| Stroke Volume | 1 | 2019 | 20 | 0.150 |
Why?
|
| Ventricular Function, Left | 1 | 2019 | 21 | 0.150 |
Why?
|
| Random Allocation | 1 | 2019 | 27 | 0.150 |
Why?
|
| Analysis of Variance | 1 | 2019 | 63 | 0.150 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 118 | 0.150 |
Why?
|
| RNA, Viral | 3 | 2013 | 20 | 0.150 |
Why?
|
| Atherosclerosis | 1 | 2019 | 39 | 0.140 |
Why?
|
| Pregnancy | 1 | 2020 | 599 | 0.140 |
Why?
|
| Feces | 2 | 2012 | 7 | 0.120 |
Why?
|
| Bangladesh | 5 | 2013 | 5 | 0.110 |
Why?
|
| Telomeric Repeat Binding Protein 2 | 1 | 2014 | 1 | 0.110 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2014 | 7 | 0.100 |
Why?
|
| Stromal Cells | 1 | 2014 | 10 | 0.100 |
Why?
|
| Skin | 1 | 2014 | 10 | 0.100 |
Why?
|
| DNA, Mitochondrial | 2 | 2019 | 9 | 0.100 |
Why?
|
| Virus Latency | 1 | 2013 | 1 | 0.100 |
Why?
|
| Simian foamy virus | 1 | 2013 | 1 | 0.100 |
Why?
|
| Proviruses | 1 | 2013 | 2 | 0.100 |
Why?
|
| Retroviridae Infections | 1 | 2013 | 2 | 0.100 |
Why?
|
| Female | 2 | 2020 | 4060 | 0.100 |
Why?
|
| Transcription, Genetic | 1 | 2013 | 40 | 0.100 |
Why?
|
| Primates | 1 | 2012 | 2 | 0.100 |
Why?
|
| Genetic Variation | 1 | 2012 | 40 | 0.090 |
Why?
|
| Phylogeny | 2 | 2012 | 20 | 0.090 |
Why?
|
| Influenza in Birds | 1 | 2011 | 1 | 0.090 |
Why?
|
| Influenza A Virus, H5N1 Subtype | 1 | 2011 | 1 | 0.090 |
Why?
|
| Influenza A Virus, H9N2 Subtype | 1 | 2011 | 1 | 0.090 |
Why?
|
| Commerce | 1 | 2011 | 4 | 0.090 |
Why?
|
| Birds | 1 | 2011 | 4 | 0.090 |
Why?
|
| HeLa Cells | 1 | 2008 | 15 | 0.070 |
Why?
|
| DNA Repair | 1 | 2008 | 7 | 0.070 |
Why?
|
| Microsatellite Repeats | 1 | 2007 | 2 | 0.070 |
Why?
|
| Polymorphism, Genetic | 1 | 2007 | 9 | 0.070 |
Why?
|
| Sequence Analysis, DNA | 3 | 2012 | 18 | 0.060 |
Why?
|
| Molecular Sequence Data | 3 | 2012 | 70 | 0.060 |
Why?
|
| High Fructose Corn Syrup | 1 | 2024 | 5 | 0.050 |
Why?
|
| Lipolysis | 1 | 2023 | 13 | 0.050 |
Why?
|
| Phenotype | 1 | 2023 | 91 | 0.050 |
Why?
|
| Cytokines | 1 | 2023 | 80 | 0.050 |
Why?
|
| Liver | 1 | 2024 | 157 | 0.050 |
Why?
|
| Molecular Epidemiology | 2 | 2012 | 3 | 0.050 |
Why?
|
| Serotyping | 2 | 2012 | 3 | 0.050 |
Why?
|
| Cluster Analysis | 2 | 2012 | 11 | 0.040 |
Why?
|
| Apolipoproteins E | 1 | 2019 | 6 | 0.040 |
Why?
|
| Inhalation Exposure | 1 | 2019 | 9 | 0.040 |
Why?
|
| Mice, Knockout, ApoE | 1 | 2019 | 10 | 0.040 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2019 | 29 | 0.040 |
Why?
|
| Reactive Oxygen Species | 1 | 2019 | 45 | 0.040 |
Why?
|
| Transcriptome | 1 | 2019 | 31 | 0.040 |
Why?
|
| Mutation | 1 | 2019 | 97 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2014 | 24 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2014 | 26 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2014 | 22 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2014 | 45 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 90 | 0.030 |
Why?
|
| Gene Products, gag | 1 | 2013 | 1 | 0.030 |
Why?
|
| Virus Replication | 1 | 2013 | 7 | 0.030 |
Why?
|
| Cheek | 1 | 2013 | 3 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2013 | 12 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2014 | 190 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2014 | 234 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2014 | 72 | 0.020 |
Why?
|
| Animals, Zoo | 1 | 2012 | 1 | 0.020 |
Why?
|
| Viral Structural Proteins | 1 | 2012 | 1 | 0.020 |
Why?
|
| Sequence Homology | 1 | 2012 | 1 | 0.020 |
Why?
|
| Haplorhini | 1 | 2012 | 2 | 0.020 |
Why?
|
| Zoonoses | 1 | 2012 | 2 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2014 | 143 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2012 | 43 | 0.020 |
Why?
|
| Neoplasms | 1 | 2014 | 92 | 0.020 |
Why?
|
| Hemagglutination | 1 | 2011 | 2 | 0.020 |
Why?
|
| Geography | 1 | 2011 | 5 | 0.020 |
Why?
|
| Prevalence | 1 | 2011 | 259 | 0.020 |
Why?
|
| Haplotypes | 1 | 2007 | 3 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2007 | 3 | 0.020 |
Why?
|
| Likelihood Functions | 1 | 2007 | 4 | 0.020 |
Why?
|
| DNA Primers | 1 | 2007 | 23 | 0.020 |
Why?
|
| Demography | 1 | 2007 | 26 | 0.020 |
Why?
|
| Base Sequence | 1 | 2007 | 65 | 0.020 |
Why?
|